Alice T. Shaw - Researcher Profile | RDL Research Database

Publications

3 shown

Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors

Lecia V. Sequist , Belinda A. Waltman , Dora Dias‐Santagata +19 more

Lung cancers undergo dynamic genetic and histological changes upon developing resistance to EGFR inhibitors.

2011 Science Translational Medicine 3483 citations

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

Robert C. Doebele , Alexander Drilon , Luis Paz‐Ares +35 more

Ignyta/F Hoffmann-La Roche.

2019 The Lancet Oncology 1625 citations

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis , Michael E. Goldberg , Danielle Greenawalt +66 more

Abstract KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct subgroups o...

2018 Cancer Discovery 1505 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 6,613
Institution: Harvard University

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-6337-1093

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.